Please find enclosed the 2024 Annual Report for Exact Therapeutics.

For further information, please contact:

Per Walday 
CEO EXACT Therapeutics
Email: per.walday@exact-tx.com 

John M. Edminson 
CFO EXACT Therapeutics 
Email: john.edminson@exact-tx.com 

About EXACT-Tx: 

EXACT Therapeutics is a clinical-stage precision medicine company utilizing the
power of ultrasound and microbubbles to enable targeted drug delivery in
oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be
applied to a wide range of therapeutic agents within oncology and across a
multitude of other indications, including brain diseases. www.exact-tx.com 

Forward looking statements: 

This announcement and any materials distributed in connection with this
announcement may contain certain forward-looking statements. By their nature,
forward-looking statements involve risk and uncertainty because they reflect the
Company's current expectations and assumptions as to future events and
circumstances that may not prove accurate. A number of material factors could
cause actual results and developments to differ materially from those expressed
or implied by this forward-looking statement. 

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.